GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 1,505.00
+11.00 (0.74%)
At close: Aug 12, 2026
GeneMatrix Market Cap
GeneMatrix has a market cap or net worth of 30.69 billion as of August 12, 2026. Its market cap has decreased by -42.67% in one year.
Market Cap
30.69B
Enterprise Value
n/a
Revenue
4.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,505.00
ChartMarket Cap Chart
Since November 6, 2009, GeneMatrix's market cap has decreased from 33.85B to 30.69B, a decrease of -9.33%. That is a compound annual growth rate of -0.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 30.69B | -38.70% |
| Dec 30, 2025 | 50.07B | -9.74% |
| Dec 30, 2024 | 55.47B | -12.40% |
| Dec 28, 2023 | 63.32B | -23.43% |
| Dec 29, 2022 | 82.69B | -58.54% |
| Dec 30, 2021 | 199.45B | -62.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 202.07B |
| GENINUS | 92.57B |
| Cytogen | 84.67B |
| Inventera | 65.05B |
| Protia | 64.01B |
| GC Medical Science | 63.05B |
| HLB Panagene | 51.95B |
| Seoulin Bioscience | 41.54B |